跳至主要内容
临床试验/ACTRN12621001156875
ACTRN12621001156875尚未招募未知

POlysaccharide haemostat for WounD haEmatomas Reduction in Cardiac Implantable Electronic Devices procedures in Adults – a Randomised Controlled Trial

The University of Adelaide0 个研究点目标入组 1,032 人开始时间: 2021年8月27日最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
1,032

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patient is equal to or greater than 18 years of age
  • Undergoing elective CIED procedure (i.e. de novo device implantation or pulse generator change or lead replacement or pocket revision)
  • Willing and able to comply with scheduled follow-up and study related activities

排除标准

  • Unwilling or unable to provide informed consent
  • Prior history of, or ongoing CIED infection (i.e. undergoing device explant)
  • Receiving thrombolytic therapy (e.g. streptokinase, urokinase, t-PT) within 24 hours
  • Medical history of coagulopathy
  • Sensitivity to starch or starch-derived materials
  • Pregnancy

研究者

相似试验